These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 3956883)

  • 1. Streptococcal preparation (OK-432) inhibits development of type I diabetes in NOD mice.
    Toyota T; Satoh J; Oya K; Shintani S; Okano T
    Diabetes; 1986 Apr; 35(4):496-9. PubMed ID: 3956883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment with streptococcal preparation (OK-432) suppresses anti-islet autoimmunity and prevents diabetes in BB rats.
    Satoh J; Shintani S; Oya K; Tanaka S; Nobunaga T; Toyota T; Goto Y
    Diabetes; 1988 Sep; 37(9):1188-94. PubMed ID: 3044884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of action of a streptococcal preparation (OK-432) in prevention of autoimmune diabetes in NOD mice. Suppression of generation of effector cells for pancreatic B cell destruction.
    Shintani S; Satoh J; Seino H; Goto Y; Toyota T
    J Immunol; 1990 Jan; 144(1):136-41. PubMed ID: 2295787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The biological response modifier OK-432 (a streptococcal preparation) inhibits the development of autoimmune kidney disease in NZB/W F1 hybrid mice: possible involvement of tumor necrosis factor.
    Mihara M; Ohsugi Y
    Int Arch Allergy Appl Immunol; 1989; 90(1):37-42. PubMed ID: 2807578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of autoimmune diabetes in NOD mice with serum from streptococcal preparation (OK-432)-injected mice.
    Seino H; Satoh J; Shintani S; Takahashi K; Zhu XP; Masuda T; Nobunaga T; Saito M; Terano Y; Toyota T
    Clin Exp Immunol; 1991 Dec; 86(3):413-8. PubMed ID: 1747949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New approach to management of malignant ascites with streptococcal preparation OK-432. III. OK-432 attracts natural killer cells through a chemotactic factor released from activated neutrophils.
    Hayashi Y; Torisu M
    Surgery; 1990 Jan; 107(1):74-84. PubMed ID: 2404351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiherpes activity of the immunomodulator OK-432, a streptococcal preparation, in immunosuppressed mice.
    Ikeda S; Sai K; Nishimura C; Yamamoto A
    Antiviral Res; 1988 Dec; 10(6):299-304. PubMed ID: 2854959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of type 1 diabetes in BB rats with recombinant human tumor necrosis factor-alpha.
    Satoh J; Seino H; Shintani S; Tanaka S; Ohteki T; Masuda T; Nobunaga T; Toyota T
    J Immunol; 1990 Sep; 145(5):1395-9. PubMed ID: 2384663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful adoptive immunotherapy with OK432-inducible activated natural killer cells in tumor-bearing mice.
    Yamaue H; Tanimura H; Iwahashi M; Tsunoda T; Tani M; Inoue M
    Biotherapy; 1990; 2(1):51-61. PubMed ID: 2400628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Augmentation by OK-432 of generation of culture-induced killer cells.
    Ujiie T
    Jpn J Exp Med; 1987 Jun; 57(3):153-61. PubMed ID: 3682231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in immunological parameters in lung cancer patients undergoing immunotherapy with streptococcal preparation OK-432.
    Watanabe Y; Shimizu J; Hashizume Y; Tsunamura Y; Yamada T; Iwa T; Sakai S; Murayama T; Koshimura S; Saito M
    Biotherapy; 1990; 2(3):235-45. PubMed ID: 2206775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The effect of OK-432 in the treatment of primary lung cancer].
    Kishimoto T; Okada K
    Gan To Kagaku Ryoho; 1987 Apr; 14(4):1051-6. PubMed ID: 3494430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor effect in peritoneal carcinomatosis of intraperitoneal administration of a streptococcal preparation, OK-432: I. Experimental study in the rat.
    Saji S; Umemoto T; Kida H; Sakata K
    J Surg Oncol; 1985 Sep; 30(1):46-51. PubMed ID: 4079418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Orally administered streptococcal preparation, OK-432 augments the antitumor immunity of patients with gastric or colorectal cancer.
    Nio Y; Ohgaki K; Tsuchitani T; Imai S; Shiraishi T; Tobe T
    Biotherapy; 1990; 2(3):213-22. PubMed ID: 2206774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Role of the spleen in OK-432 immunotherapy and characterization of effector cells].
    Yamagishi H; Naito K; Maeda Y; Kobayashi M; Kurioka H; Fujimori C; Tanaka T; Hashimoto I
    Gan To Kagaku Ryoho; 1983 Jul; 10(7):1670-8. PubMed ID: 6870309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Successful adoptive immunotherapy with OK432-inducible activated natural killer cells on tumor-bearing mice].
    Yamaue H; Tanimura H; Iwahashi M; Tani M; Tsunoda T; Tabuse K
    Nihon Gan Chiryo Gakkai Shi; 1989 Dec; 24(11):2546-55. PubMed ID: 2614190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal antibody to the streptococcal preparation OK-432: tissue OK-432 localization and analysis of interaction between OK-432 and macrophages or NK cells in human salivary adenocarcinoma-bearing nude mice given OK-432.
    Sato M; Kaji R; Urata M; Yoshida H; Yanagawa T; Miyamoto K; Azuma M; Furumoto N; Saito M
    J Biol Response Mod; 1988 Apr; 7(2):212-28. PubMed ID: 3361352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study on pancreatic lymphatics in nonobese diabetic mouse with prevention of insulitis and diabetes by adjuvant immunotherapy.
    Qu P; Ji RC; Shimoda H; Miura M; Kato S
    Anat Rec A Discov Mol Cell Evol Biol; 2004 Dec; 281(2):1326-36. PubMed ID: 15386276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-tumor effects of the oral administration of the streptococcal preparation OK-432 (PICIBANIL)--the inhibition of carcinogenesis and growth in rats with ENNG-induced gastrointestinal tumors.
    Takeshita M; Makita F; Takeyoshi I; Ishikawa H; Nakamura S; Owada S; Miyamoto Y; Izuo M; Kurashige S
    Jpn J Surg; 1990 May; 20(3):316-26. PubMed ID: 2359208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal antibody to a human salivary gland adenocarcinoma cell line: augmentation of antibody-dependent cell-mediated cytotoxicity activity by streptococcal preparation OK-432 in human salivary gland adenocarcinoma-bearing nude mice given the antibody.
    Kaji R; Yoshida H; Yanagawa T; Sato M
    J Biol Response Mod; 1989 Oct; 8(5):488-500. PubMed ID: 2552025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.